Simplicity Wealth
AUTL icon

Simplicity Wealth’s Autolus Therapeutics AUTL Stock Holding History

Simplicity Wealth’s Portfolio AUTL Stock Details AUTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$21K Buy
+10,838
New +$20.7K ﹤0.01% 1065

Other funds holding AUTL

Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Apollon Wealth Management
Apollon Wealth Management Mount Pleasant, South Carolina $8.72B AUM 23.07% 1-Year Est. Return
Wealth Effects
Wealth Effects Boston, Massachusetts $370M AUM 63.53% 1-Year Est. Return
Meridian Financial Partners
Meridian Financial Partners Warrenton, Virginia $306M AUM 22.08% 1-Year Est. Return
Byrne Asset Management
Byrne Asset Management Kingston, New Jersey $179M AUM 29.67% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Simplicity Wealth's AUTL Position: Q3 2026 in Review

Simplicity Wealth opened a new position in Autolus Therapeutics (AUTL) in Q3 2026: 10,838 shares worth $21K. The stake represents ﹤0.01% of the portfolio and ranks #1065 among its holdings.

8 funds tracked by Wall St. Rank hold AUTL as of Q3 2026.

  • Simplicity Wealth held 10,838 shares of Autolus Therapeutics worth $21K as of Q3 2026.
  • Autolus Therapeutics was a new Simplicity Wealth position in Q3 2026.
  • Autolus Therapeutics made up ﹤0.01% of Simplicity Wealth's portfolio in Q3 2026, its #1065 holding.
  • 8 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q3 2026.

Based on Simplicity Wealth's 13F filing for Q3 2026, filed 23 Oct 2026.